James V. Caruso, President and CEO at Cellectar Biosciences, Inc. (CLRB), bought 5,100 shares at $1.70 ($9K) on 2021-03-04, disclosed to the SEC on 2021-03-05.
Open-market purchase of $9k CLRB by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| CLRB | BUY | 2020-12-28 | $50K | — | Filing → |
| CLRB | BUY | 2020-06-08 | $25K | — | Filing → |
| CLRB | BUY | 2018-11-30 | $2K | — | Filing → |